Equity Overview
Price & Market Data
Price: $1.42
Daily Change: +$0.0₃3 / 0.02%
Daily Range: $1.42 - $1.48
Market Cap: $24,509,496
Daily Volume: 252,959
Performance Metrics
1 Week: 3.52%
1 Month: 59.78%
3 Months: 52.33%
6 Months: -11.98%
1 Year: -61.82%
YTD: -55.18%
Company Details
Employees: 5
Sector: Health technology
Industry: Biotechnology
Country:
Details
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.